Gilead/Arcellx’s anito-cel’s differentiated safety profile challenges J&J/Legend’s Carvykti

Anito-cel has shown no signs of delayed neurotoxicity at around 9 months of follow-up, hinting at a safety profile that could set it apart from J&J and Legend’s Carvykti.